Pfizer and BioNTech's Covid-19 vaccine is poised with an emergency use approval after the U.S. Food and Drug Administration released a report that found no issues with the vaccine's efficacy or safety.
Last month, Pfizer and BioNTech stated that their vaccine’s two-dose regimen was 95% effective against Covid-19 and had no major safety issues. The FDA staff's report was consistent with Pfizer and BioNTech's findings.
The report has been release ahead of a Thursday meeting where outside experts will discuss whether to recommend the treatment for people aged 16 and older.
The UK has already approved the Pfizer vaccine.
A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data, with a vote expected on Sunday on recommendations to doctors on how it should be used.
Read the FDA report